The Global Endotherapy Devices Market was valued at USD 5.6 billion in 2025 and is estimated to grow at a CAGR of 7.6% to reach USD 11.7 billion by 2035.
Market expansion is driven by the increasing shift toward minimally invasive treatment approaches, rapid innovation in therapeutic endoscopy technologies, and the growing number of outpatient and ambulatory care facilities. Endotherapy devices are specialized instruments designed to support therapeutic procedures performed through endoscopic access, enabling internal treatment without large surgical incisions. These devices allow clinicians to perform targeted therapeutic interventions with improved accuracy and reduced patient recovery time. Rising procedural volumes across healthcare systems are reinforcing demand for advanced endotherapy solutions. Continuous improvements in visualization quality, device flexibility, energy delivery systems, and automation are enhancing procedural precision and patient safety. These advancements are broadening the range of conditions that can be managed endoscopically, reducing reliance on conventional surgery. Ongoing technology upgrades are also contributing to replacement demand, as healthcare providers prioritize modern systems that deliver better clinical outcomes and operational efficiency.
Endotherapy platforms are becoming increasingly sophisticated, integrating high-definition imaging, enhanced contrast visualization, and advanced optical technologies. These features support improved detection capabilities and more accurate therapeutic delivery, strengthening clinical confidence and improving procedural success rates. Enhanced visualization continues to play a central role in expanding adoption across healthcare facilities.
The gastrointestinal devices and accessories segment accounted for 56.4% share in 2025, supported by consistently high procedure volumes and widespread use of therapeutic tools in routine endoscopic care. The segment maintains its leadership position due to the broad application of gastrointestinal endotherapy across diagnostic and interventional procedures. Growing utilization of endoscopic treatment methods continues to support sustained demand for specialized accessories and devices within this category.
The hospitals segment generated 54.6% share in 2025 and is expected to reach USD 6.2 billion during 2026-2035. Hospitals manage a wide range of patient cases and perform a high volume of complex and multidisciplinary procedures, driving consistent demand for advanced endotherapy technologies. These facilities are equipped with comprehensive endoscopy infrastructure, advanced imaging systems, and specialized clinical expertise, reinforcing their dominance in market adoption.
U.S. Endotherapy Devices Market was valued at USD 2.3 billion in 2025. Strong reimbursement coverage for endoscopic procedures and supportive healthcare funding structures continue to encourage investment in modern endotherapy equipment, sustaining high utilization rates across care settings.
Key companies active in the Global Endotherapy Devices Market include Medtronic, OLYMPUS, Boston Scientific, KARL STORZ, FUJIFILM, Johnson & Johnson, Cook Medical, CONMED, Smith+Nephew, Stryker, B. BRAUN, Endo-Med, MICRO-TECH, M.I. Tech, and TAEWOONG MEDICAL. These companies maintain competitive positions through innovation, product breadth, and global distribution networks. To strengthen their presence, companies in the endotherapy devices sector focus heavily on continuous product innovation and technological differentiation. Strategic investments in advanced imaging, energy-based tools, and device miniaturization enhance clinical performance and usability. Manufacturers are expanding geographic reach through partnerships, acquisitions, and distribution agreements to access high-growth markets. Training programs and physician education initiatives are used to drive adoption and long-term customer loyalty.
This product will be delivered within 2-4 business days.
Market expansion is driven by the increasing shift toward minimally invasive treatment approaches, rapid innovation in therapeutic endoscopy technologies, and the growing number of outpatient and ambulatory care facilities. Endotherapy devices are specialized instruments designed to support therapeutic procedures performed through endoscopic access, enabling internal treatment without large surgical incisions. These devices allow clinicians to perform targeted therapeutic interventions with improved accuracy and reduced patient recovery time. Rising procedural volumes across healthcare systems are reinforcing demand for advanced endotherapy solutions. Continuous improvements in visualization quality, device flexibility, energy delivery systems, and automation are enhancing procedural precision and patient safety. These advancements are broadening the range of conditions that can be managed endoscopically, reducing reliance on conventional surgery. Ongoing technology upgrades are also contributing to replacement demand, as healthcare providers prioritize modern systems that deliver better clinical outcomes and operational efficiency.
Endotherapy platforms are becoming increasingly sophisticated, integrating high-definition imaging, enhanced contrast visualization, and advanced optical technologies. These features support improved detection capabilities and more accurate therapeutic delivery, strengthening clinical confidence and improving procedural success rates. Enhanced visualization continues to play a central role in expanding adoption across healthcare facilities.
The gastrointestinal devices and accessories segment accounted for 56.4% share in 2025, supported by consistently high procedure volumes and widespread use of therapeutic tools in routine endoscopic care. The segment maintains its leadership position due to the broad application of gastrointestinal endotherapy across diagnostic and interventional procedures. Growing utilization of endoscopic treatment methods continues to support sustained demand for specialized accessories and devices within this category.
The hospitals segment generated 54.6% share in 2025 and is expected to reach USD 6.2 billion during 2026-2035. Hospitals manage a wide range of patient cases and perform a high volume of complex and multidisciplinary procedures, driving consistent demand for advanced endotherapy technologies. These facilities are equipped with comprehensive endoscopy infrastructure, advanced imaging systems, and specialized clinical expertise, reinforcing their dominance in market adoption.
U.S. Endotherapy Devices Market was valued at USD 2.3 billion in 2025. Strong reimbursement coverage for endoscopic procedures and supportive healthcare funding structures continue to encourage investment in modern endotherapy equipment, sustaining high utilization rates across care settings.
Key companies active in the Global Endotherapy Devices Market include Medtronic, OLYMPUS, Boston Scientific, KARL STORZ, FUJIFILM, Johnson & Johnson, Cook Medical, CONMED, Smith+Nephew, Stryker, B. BRAUN, Endo-Med, MICRO-TECH, M.I. Tech, and TAEWOONG MEDICAL. These companies maintain competitive positions through innovation, product breadth, and global distribution networks. To strengthen their presence, companies in the endotherapy devices sector focus heavily on continuous product innovation and technological differentiation. Strategic investments in advanced imaging, energy-based tools, and device miniaturization enhance clinical performance and usability. Manufacturers are expanding geographic reach through partnerships, acquisitions, and distribution agreements to access high-growth markets. Training programs and physician education initiatives are used to drive adoption and long-term customer loyalty.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Research Methodology
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2025
Chapter 5 Market Estimates and Forecast, by Product, 2022-2035 ($ Mn)
Chapter 6 Market Estimates and Forecast, by Application, 2022-2035 ($ Mn)
Chapter 7 Market Estimates and Forecast, by End Use, 2022-2035 ($ Mn)
Chapter 8 Market Estimates and Forecast, by Region, 2022-2035 ($ Mn)
Chapter 9 Company Profiles
Companies Mentioned
The companies profiled in this Endotherapy Devices market report include:- B. BRAUN
- Boston Scientific
- CONMED
- Cook Medical
- Endo-Med
- FUJIFILM
- Johnson & Johnson
- KARL STORZ
- M.I. Tech
- Medtronic
- MICRO-TECH
- OLYMPUS
- Smith+Nephew
- Stryker
- TAEWOONG MEDICAL
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 140 |
| Published | January 2026 |
| Forecast Period | 2025 - 2035 |
| Estimated Market Value ( USD | $ 5.6 Billion |
| Forecasted Market Value ( USD | $ 11.7 Billion |
| Compound Annual Growth Rate | 7.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 16 |
